Comparison in prolactin concentration during haloperidol and risperidone treatments in the same female patients with schizophrenia

被引:0
|
作者
Yasui, N [1 ]
Kondo, T [1 ]
Suzuki, A [1 ]
Mihara, K [1 ]
Ono, S [1 ]
Kaneko, S [1 ]
机构
[1] Hirosaki Univ, Sch Med, Dept Clin Pharmacol, Hirosaki, Aomori 036, Japan
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:S67 / S68
页数:2
相关论文
共 50 条
  • [31] The Therapeutic Effectiveness of Risperidone on Negative Symptoms of Schizophrenia in Comparison with Haloperidol: A Randomized Clinical Trial
    Mirabzadeh, Arash
    Kimiaghalam, Pooneh
    Fadai, Farbod
    Samiei, Mercedeh
    Daneshmand, Reza
    BASIC AND CLINICAL NEUROSCIENCE, 2014, 5 (03) : 212 - 217
  • [32] Effect of haloperidol and risperidone on neuromarkers and indices of endothelial dysfunction in patients with acute schizophrenia
    Govorin, N. V.
    Vasileva, A. I.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2011, 111 (03) : 54 - 57
  • [33] Predictors and rates of rehospitalization of patients with schizophrenia discharged on a regimen of haloperidol or risperidone or clozapine
    Werneck, A. P.
    Elkis, H.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 168 - 168
  • [34] Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder
    Volavka, J
    Czobor, P
    Sheitman, B
    Lindenmayer, JP
    Citrome, L
    McEvoy, JP
    Cooper, TB
    Chakos, M
    Lieberman, JA
    AMERICAN JOURNAL OF PSYCHIATRY, 2002, 159 (02): : 255 - 262
  • [35] Antipsychotic treatments for schizophrenia: A cost-effectiveness analysis comparing haloperidol, olanzapine, risperidone and ziprasidone.
    Augustovski, F
    Krupitzky, H
    Laffaire, E
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2003, 18 : 162 - 162
  • [36] Comparison of risperidone oral solution and intramuscular haloperidol with the latter shifting to oral therapy for the treatment of acute agitation in patients with schizophrenia
    Fang, Maosheng
    Chen, Honghui
    Li, Le-hua
    Wu, Renrong
    Li, Yi
    Liu, Lianzhong
    Ye, Meng
    Huang, Jizhong
    Zhu, Suoyu
    Wang, Gang
    Zhang, Qinge
    Zheng, Hongbo
    Zhang, Lulu
    Wang, Bo
    Zhou, Jianchu
    Zhao, Jing-Ping
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2012, 27 (02) : 107 - 113
  • [37] Comparison of prolactin level in schizophrenia patients treated with risperidone oral or long-acting injections - preliminary report
    Skowronska, Anna
    Strzelecki, Dominik
    Wysokinski, Adam
    ARCHIVES OF CLINICAL PSYCHIATRY, 2021, 48 (01) : 20 - 23
  • [38] Cardiovascular variability during treatment with haloperidol, olanzapine or risperidone in recent-onset schizophrenia
    Hempel, R. J.
    Tulen, J. H. M.
    van Beveren, N. J. M.
    Roder, C. H.
    Hengeveld, M. W.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2009, 23 (06) : 697 - 707
  • [39] A comparison of serum prolactin concentrations after administration of paliperidone extended-release and risperidone tablets in patients with schizophrenia
    Berwaerts, Joris
    Cleton, Adriaan
    Rossenu, Stefaan
    Talluri, Krishna
    Remmerie, Bart
    Janssens, Luc
    Boom, Sandra
    Kramer, Michelle
    Eerdekens, Marielle
    JOURNAL OF PSYCHOPHARMACOLOGY, 2010, 24 (07) : 1011 - 1018
  • [40] Prolactin levels in schizophrenic patients receiving perospirone in comparison to risperidone
    Togo, T
    Iseki, E
    Shoji, M
    Oyama, L
    Kase, A
    Uchikado, H
    Katsuse, O
    Kosaka, K
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2003, 91 (03) : 259 - 262